Rhenman & Partners Asset Management AB
Position in MRK — Merck & Co., Inc.
CIK 1599882
Stockholm, V7
Position in MRK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$27,434,750
+$24,472,670 QoQ
Shares Held
213,500
+547.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
2.59%
of 13F equity value
Holder Rank
#439
of 3,769 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rhenman & Partners Asset Management AB holds $173,015,372 across 8 Drug Manufacturers - General names. MRK ranks #2 (15.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
151,500 | $28,727,430 | |
| 2 | MRK |
Merck & Co., Inc.
This page
|
213,500 | $27,434,750 | |
| 3 | LLY |
ELI LILLY & Co
|
22,315 | $26,765,282 | |
| 4 | ABBV |
AbbVie Inc.
|
96,775 | $24,352,461 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
178,250 | $22,520,105 | |
| 6 | BIIB |
Biogen Inc.
|
94,850 | $20,493,291 | |
| 7 | JNJ |
Johnson & Johnson
|
72,500 | $18,412,825 | |
| 8 | AMGN |
Amgen Inc
|
11,900 | $4,309,228 |
All Filings in MRK
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,434,750 | 213,500 | Shares | Sole | 2026-08-13 | |
| 2025-03-31 | $2,962,080 | 33,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $27,605,700 | 277,500 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $27,367,960 | 241,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $21,665,000 | 175,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $28,831,075 | 218,500 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $16,080,450 | 147,500 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $19,560,500 | 190,000 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $21,924,100 | 190,000 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $25,639,990 | 241,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $23,854,250 | 215,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $18,515,800 | 215,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $24,160,050 | 265,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $18,461,250 | 225,000 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $22,992,000 | 300,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $22,533,000 | 300,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $23,331,000 | 300,000 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $20,814,311 | 270,000 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $28,140,823 | 344,020 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $13,272,006 | 160,000 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $12,372,805 | 160,000 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $12,695,094 | 165,000 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||